Social Space - Cancer

Inflammatory breast cancer, or IBC, is a rare form of breast cancer. It is estimated to occur in only 1 - 3% of all breast cancer patients. It usually occurs in post-menopausal women, but cases have been found in

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

girls as young as 12 and in men. IBC is usually diagnosed at an earlier age than other forms of breast cancer and is more common in African American women than in Caucasian women. This cancer has a higher mortal

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ity rate because it is often misdiagnosed in the early, more treatable stages. However, advances in cancer research have improved the survival rate.

This cancer grows rapidly; your symptoms will appear in a matte

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

r of days or weeks. Women with inflammatory breast cancer often have no idea that they have breast cancer because IBC does not usually form a lump in the breast. Instead, this cancer forms 'sheets' of cancer cell

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s making your breast feel thicker or heavier than usual. Other symptoms of IBC include swelling and tenderness of the breast, discoloration (usually red to purple) of the breast, itching or pain in the breast, dim

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

pled or rough looking skin on the breast, swelling or crusting of the skin on the nipple and flattening or retraction of the nipple. Many of these symptoms mimic those of a breast infection, or mastitis. Mastitis

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

usually causes a fever and usually occurs in younger breast-feeding mothers. Mastitis will respond to antibiotics. IBC, which has been documented in breast-feeding women, does not cause a fever nor respond to an

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ibiotics.

Because the symptoms of IBC are so similar to mastitis and because inflammatory breast cancer is so rare, many doctors misdiagnose this cancer as mastitis. Patients are often prescribed multiple rounds

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

of antibiotics because it doesn't clear up after the first round. If you have these symptoms and your doctor wants you to take more than one round of antibiotics, ask for a biopsy or referral to a breast specialis

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

t. You may have to be very aggressive to get the proper diagnosis. This is vital because the earlier this is diagnosed, the sooner you can begin treatment and the better your survival chances.

A proper cancer di

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

agnosis usually results from elimination of mastitis as a culprit, with the symptoms still present and possibly getting worse. Your doctor may schedule you for a mammogram or a breast sonogram to confirm the diagn

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

osis, but these are not very reliable with this cancer because the affected area may not show up. A biopsy is the most effective way to confirm diagnosis of this cancer, however it may still be wrong if your docto

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

r biopsies the wrong area of your breast. Because this cancer does grow very rapidly, your doctor may also schedule other tests to determine if your cancer has spread to other organs in your body. This will affec

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t your course of treatment.

Your treatment depends largely upon whether your cancer has spread to other organs of your body. You will most likely have a team of doctors talking with you, trying to determine the b

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

st course of treatment for you. You will receive aggressive treatment because inflammatory breast cancer is a late stage cancer. This means you will most likely receive chemotherapy, surgery and radiation therapy

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

. You will most likely receive chemotherapy first because this cancer makes performing surgery first risky due to the skin changes it causes. Chemotherapy also works to shrink the size of the cancer, making it mo

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

re likely that surgery will remove all of it. The surgery that most women choose with this cancer is a mastectomy, or complete removal of the affected breast. This is because the cancer is often widespread throug

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

hout the breast, making a surgery that preserves breast tissue highly unlikely.

During surgery, your surgeon will probably remove the lymph nodes under your arm to examine them for cancer. After surgery, you will

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

most likely receive radiation therapy. Radiation therapy is used to kill any cancer cells that the surgeon may have missed and to help prevent the cancer from returning. Inflammatory breast cancer has a high inc

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

idence of recurrence, so your doctor may prescribe additional rounds of chemotherapy if you responded well to the previous rounds or hormone therapy if your cancer was the type that grew in the presence of estrogen

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.socialspace.org.ua/article/389632/socialspace-Inflammatory-Breast-Cancer.html">Inflammatory Breast Cancer</a>

BB link (for phorums):
[url=http://www.socialspace.org.ua/article/389632/socialspace-Inflammatory-Breast-Cancer.html]Inflammatory Breast Cancer[/url]

Having formed a limited company you will probably get on with making your business a success. However you have probably not considered the potential for your company to be hijacked. Without your knowledge an individual may steal the identity of your company and begin to open bank accounts and enter into fraudulent contracts. A few simple steps can help to prevent this from occurring.

There are many online companies that offer romantic honeymoon getaways on both the Pacific and Caribbean coasts of Costa Rica. Having just returned from Costa Rica myself, I would like to offer some suggestions that you probably will not find online or in a guidebook.

Solid Oak is a wonderful way to enjoy long lasting furniture and is diverse enough to go in any room in the home. Although it is most commonly associated with

Tags

Links

Social Space - Inflammatory Breast Cancer

Related Articles: